Evidence map›Paper›PMID 29686039›Full record

ReviewCold Spring Harbor perspectives in medicine2019

Stem Cell-Derived Culture Models of Hepatitis E Virus Infection.

Viet Loan Dao Thi, Xianfang Wu, Charles M Rice

Abstract readReview
In one paragraph

Review in Cold Spring Harbor perspectives in medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Liver Organoid Potential Application for Hepatitis E Virus Infection.Advances in experimental medicine and biology · 2023
    Article
  3. Review
  4. Review
  5. Stem cell-derived polarized hepatocytes.Nature communications · 2020
    Article
  6. Robust hepatitis E virus infection and transcriptional response in human hepatocytes.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Life cycle and morphogenesis of the hepatitis E virus.Emerging microbes & infections · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Viet Loan Dao ThiLaboratory of Virology and Infectious Diseases, The Rockefeller University, New York, New York 10065.
Xianfang WuLaboratory of Virology and Infectious Diseases, The Rockefeller University, New York, New York 10065.
Charles M RiceLaboratory of Virology and Infectious Diseases, The Rockefeller University, New York, New York 10065.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Similar to other hepatotropic viruses, hepatitis E virus (HEV) has been notoriously difficult to propagate in cell culture, limiting studies to unravel its biology. Recently, major advances have been made by passaging primary HEV isolates and selecting variants that replicate efficiently in carcinoma cells. These adaptations, however, can alter HEV biology. We have explored human embryonic or induced pluripotent stem cell (hESC/iPSC)-derived hepatocyte-like cells (HLCs) as an alternative to conventional hepatoma and hepatocyte cell culture systems for HEV studies. HLCs are permissive for nonadapted HEV isolate genotypes (gt)1-4 replication and can be readily genetically manipulated. HLCs, therefore, enable studies of pan-genotype HEV biology and will serve as a platform for testing anti-HEV treatments. Finally, we discuss how hepatocyte polarity is likely an important factor in the maturation and spread of infectious HEV particles.

Indexed as

Cell Culture TechniquesAdaptation, PhysiologicalCarcinoma, HepatocellularHepatitis EHepatitis E virusHumansLiver NeoplasmsStem CellsTumor Cells, CulturedVirus Replication

Identifiers

PMID29686039
PMCPMC6396339

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.